Pancreatic cancer patient symposium Feb. 9
Provides info on latest in research, treatment
Pancreatic cancer is the nation’s No. 4 cancer killer, but a diagnosis is not a death sentence, as research and new potential therapies provide hope for patients each day.
To educate on these latest breakthroughs as well as the spectrum of the illness, including screening, evaluation, personalized treatment approaches and survivorship care, the University of Cincinnati (UC) Cancer Institute is hosting an educational event for patients, survivors, their families and the community.
Cooper Creek Event and Conference Center
The event, being held from 1 p.m. to 4 p.m. Saturday, Feb. 9, at the Cooper Creek Event and Conference Center, 4040 Cooper Rd., Blue Ash, will involve presentations from experts within the institute at UC, the community, patients and more.
Talks will touch on symptom management, nutritional guidelines and the patient experience of living with and surviving pancreatic cancer. Additionally, attendees will hear from caregivers and family members of those with the disease and will have an opportunity to ask UC experts questions. UC Health’s Integrative Medicine will be on hand, as well, to offer tips on mindful relaxation techniques.
“We hope this event will help raise awareness about pancreas cancer in the community and highlight new, groundbreaking treatment strategies,” adds Sameer Patel, MD, assistant professor of surgery at the UC College of Medicine, UC Health surgical oncologist and a member of the UC Cancer Institute.
Light refreshments will be provided. For more information, contact Kelly Hummel at 513-558-2030.
Featured photo of Sameer Patel, MD / Credit: Tommy Campbell, UC Health
Related Stories
Chris Higgins named UC Foundation Vice President for Development, Academic Health Enterprise
January 6, 2026
The University of Cincinnati Foundation is pleased to welcome Chris Higgins as the new Vice President for Development, Academic Health Enterprise.
What's behind the mysterious rise of migraines?
January 5, 2026
Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.
Top six 2025 nephrology drug approvals
January 5, 2026
“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.